1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Drug Shortages
  5. Drug Shortage Assistance Award
  1. Drug Shortages

Drug Shortage Assistance Award

As part of FDA’s work to prevent and mitigate drug shortages, the Agency has created the FDA Drug Shortage Assistance Award to provide public recognition to drug companies and manufacturers who have demonstrated a commitment to preventing or alleviating drug shortages of medically necessary drugs. This award recognizes efforts of drug companies and manufacturers who have worked in cooperation with FDA and have implemented strategies to help provide a steady supply of medically necessary drugs for patients at a time when critical drug shortages pose a challenge for health care providers and patients nationwide, while maintaining a commitment to quality manufacturing.

CompanyFDA Letter
IMS/AmphastarAward Letter (PDF - 153 KB)
Sagent PharmaceuticalsAward Letter (PDF - 125 KB)
ApotexAward Letter (PDF - 402 KB)
Fresenius Kabi USA, LLCAward Letter (PDF - 352 KB)
TevaAward Letter (PDF - 352 KB)
ADIENNE Pharma BiotechAward Letter (PDF - 76 KB)
Eurohealth International Sàrl, a subsidiary of Hikma PharmaceuticalsAward Letter (PDF - 29 KB)
Clinigen Group plcAward Letter (PDF - 32 KB)
Guerbet GroupAward Letter (PDF - 32 KB)
Back to Top